Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019
April 30 2019 - 10:45AM
Cambrex Corporation (NYSE: CBM), the leading small molecule company
providing drug substance, drug product and analytical services
across the entire drug lifecycle, today announced that first
quarter 2019 financial results will be released on Thursday, May 2,
2019 before the market opens.
The Company will host a conference call to discuss the financial
results.
|
|
|
First Quarter 2019
Earnings Conference Call |
|
|
When: |
Thursday, May 2, 2019 at
8:30 a.m. Eastern Time |
|
|
Dial-in: |
1-800-682-0995 for
U.S. |
|
1-334-323-0522 for
International |
|
Passcode:
2251796 |
|
|
Dial-in
Replay: |
1-888-203-1112 for
U.S. |
|
1-719-457-0820 for
International |
|
Passcode:
2251796 |
|
Available through
Thursday, May 9, 2019 |
|
|
Webcast: |
www.cambrex.com |
About CambrexCambrex is the
leading small molecule company that provides drug substance, drug
product and analytical services across the entire drug lifecycle.
The company provides customers with an end-to-end partnership for
the research, development and manufacture of small molecule
therapeutics. With over 35 years’ experience and a growing team of
over 2,000 experts servicing global clients from sites in North
America and Europe, Cambrex is a trusted partner in branded and
generic markets for API and dosage form development and
manufacturing.
Cambrex offers a range of specialist drug
substance technologies and capabilities including biocatalysis,
continuous flow, controlled substances, solid state science,
material characterization and highly potent APIs. In addition,
Cambrex can support conventional dosage forms including oral
solids, semi-solids and liquids and has the expertise to
manufacture specialist dosage forms such as modified-release, fixed
dose combination, pediatric, bi-layer tablets, stick packs,
topicals, controlled substances, sterile and non-sterile
ointments.
For more information, please visit
www.cambrex.com
|
|
Contact: |
Stephanie LaFiura |
|
Investor Relations Associate |
|
Tel: 201-804-3037 |
|
Email: stephanie.lafiura@cambrex.com |
Cambrex (NYSE:CBM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cambrex (NYSE:CBM)
Historical Stock Chart
From Jul 2023 to Jul 2024